# Manish R. Patel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/manish-r-patel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,820 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 59 |
| i10-index | 235 |
| Last Known Institution | Centers for Disease Control and Prevention |
| OpenAlex ID | https://openalex.org/A5005718112 |
| ORCID iD | https://orcid.org/0000-0001-6836-2364 |
| Works | 801 |

## Researcher papers

- [Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study](https://scholariq.org/papers/safety-and-activity-of-the-anti-cd79b-antibody-drug-conjugate-polatuzumab/)
- [A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i> -Mutated Ovarian Carcinoma or Other Solid Tumors](https://scholariq.org/papers/a-phase-i-ii-study-of-the-oral-parp-inhibitor-rucaparib-in-patients-with/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Researcher university

- [Centers for Disease Control and Prevention](https://scholariq.org/institutions/centers-for-disease-control-and-prevention/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.